Caga seropositivity associated with development of gastric cancer in a japanese population

Journal of Clinical Pathology

Volumn 51, Issue 3, 1998, Pages 225-228

  Shimoyama, T ^a   Fukuda, S ^a   Tanaka, M ^b   Mikami, T ^a   Munakata, A ^a   Crabtree, J E ^c  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

CagA; Gastric cancer; Helicobacter pylori

Indexed keywords

CYTOTOXIN; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; BACTERIAL GENE; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; STOMACH CANCER;

EID: 0031978227     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.3.225     Document Type: Article

References (34)

1. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
2. Siurala M, Sipponen P, Kekki M. Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol 1985;20(suppl 109):69-76.
3. Imai T, Kubo T, Watanabe H. Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma. J Natl Cancer Inst 1971;47:179-95.
4. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
5. Nomura A, Stemmermann GN, Chyou P, Kato I, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N Engl J Med 1991;325:1132-6.
6. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori infection and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-5.
7. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991;13:42-59.
8. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
9. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence for linkage to cytotoxin production. Infect Immun 1993;61:1799-809.
10. Censini S, Lange C, Xiang Z, et al. cag, a pathogenecity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996;93:14648-53.
11. Crabtree JH, Farmery SM. Helicobacter pylori and gastric mucosal cytokines: evidence that CagA-positive strains are more virulent. Lab Invest 1995;73:742-5.
12. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
13. Peek RM, Miller GG, Tham KT, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995;73:760-70.
14. Yamaoka Y, Kita M, Kodama T, Sawai M, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996;110: 1744-52.
15. Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 1996;10(suppl 1):29-37.
16. Kuipers EJ, Pérez-Pérez GL, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
17. Beales ILP, Crabtree JE, Scunes D, Covacci A, Calam J. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996;8:645-9.
18. Blaser MJ, Pérez-Pérez GI, Kleanthous H, et al. Infection of strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
19. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40: 297-301.
20. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;1:87-97.
21. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
22. Kodama A, Inokuchi K, Soejima K, Matsusaka T, Okamura T. Growth patterns and prognosis in early gastric carcinoma. Cancer 1983;51:320-6.
23. Schembri MA, Lin SK, Lambert JR. Comparison of commercial diagnostic tests for Helicobacter pylori antibodies. J Clin Microbiol 1993;31:2621-4.
24. Yamamoto I, Fukuda Y, Mizuta T, et al. Evaluation of nine commercial serodiagnostic kits for the detection of Helicobacter pylori infection in Japan. Res For Dig Dis 1994;1:75-85.
25. Xiang Z, Bugnoli M, Ponzetto A, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993;12: 739-45.
26. Peek RM, Miller GG, Tham KT, et al. Detection of Helicobacter pylori gene expression in human gastric mucosa. J Clin Microbiol 1995;33:28-32.
27. Crabtree JE, Wyatt JI, Sobala GM, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993;34:1339-43.
28. Correa P, Miller MJ. Helicobacter pylori and gastric atrophy-cancer paradoxes. J Natl Cancer Inst 1995;87: 1731-2.
29. Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 1994;56:56-60.
30. Kikuchi S, Forman D, Covacci A, Crabtree JE. Diffuse gastric cancer in young H. pylori positive Japanese patients: lack of association with CagA status. Gut 1996;39(suppl 2):A68.
31. Ito S, Azuma T, Murakita H, et al. Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut 1996;39:800-6.
32. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol 1991;44:326-8
33. Menegatti M, Vaira D, Holton J, et al. Serological response to Helicobacter pylori in gastric and non-gastric cancer. Clin Sci 1996;91:219-23.
34. Caruso ML, Fucci L. Histological identification of in Helicobacter pylori early and advanced gastric cancer. J Clin Gastroenterol 1990;12:601-2.